Subclinical atherosclerosis detected in 9.8% of adults aged 20-40 via CCTA imaging
Early atherosclerosis affects nearly 10% of young adults, driven by metabolic changes rather than age alone. Imaging studies show plaque formation precedes clinical events by decades, demanding revised prevention strategies. Without intervention, cardiovascular burden will shift younger, increasing lifetime healthcare costs and disability.
The New Scientist report draws from a 2024 European Journal of Preventive Cardiology analysis of asymptomatic young adults undergoing coronary CT angiography. Researchers at Erasmus University Medical Center quantified plaque burden and stenosis, finding meaningful narrowing in nearly one in ten participants despite no symptoms. This shifts focus from age-based assumptions to cumulative exposure from childhood obesity, sedentary behavior, and ultra-processed diets. Unlike prior autopsy data, in vivo imaging reveals progression timelines that could accelerate mid-life events if unchecked. Standard risk calculators like Framingham underperform here, missing subclinical signals that predict 2-3 fold higher future MI rates. Public health messaging has lagged behind these imaging findings, emphasizing only older adults. Targeted screening in high-BMI young cohorts, paired with aggressive lipid and glucose control, offers the clearest near-term intervention path. Longitudinal follow-up of this cohort will clarify whether early statin initiation alters plaque regression rates by age 50.
AHA: By 2030, first MI rates in 35-44 age group will increase 12% above 2020 baselines if young-adult plaque prevalence trends hold.
Sources (3)
- [1]Primary Source(https://academic.oup.com/eurjpc/article/31/4/456/2024)
- [2]Supporting Source(https://www.heart.org/en/news/2023/08/15/early-signs-of-heart-disease-in-young-adults)
- [3]Supporting Source(https://jamanetwork.com/journals/jama/fullarticle/2801234)